Last update : 07/04/2015 | Version : 1 | ID : 8593
General | |
Identification | |
Detailed name | Apathy in Schizophrenia: A Case-Control Clinical and Neuropsychological Study |
Sign or acronym | ASCHI |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL no. 912451 / CCTIRS no. 12.297 |
General Aspects | |
Medical area |
Neurology Psychology and psychiatry |
Keywords | apathy, schizophrenia |
Scientific investigator(s) (Contact) | |
Name of the director | Lévy |
Surname | Richard |
Address | Hôpital de la Pitié Salpétrière, 75013 Paris |
Phone | +33 (0)1 49 28 24 32 |
richard.levy@sat.aphp.fr | |
Unit | INSERM MEDU 945, Centre de Recherche-Institut du Cerveau et de la Moelle (CR-ICM), Hôpital de la Pitié Salpétrière |
Organization | APHP |
Collaborations | |
Funding | |
Funding status |
Public |
Details | INSERM, APHP |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | INSERM |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Case control study |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Database objective | |
Main objective |
The main objective is to confirm that schizophrenic patients are apathetic compared to health volunteers.
Secondary objectives: - to investigate if apathy is related to a particular aspect of the disease (i.e., negative or positive symptomatology); - to investigate if apathy correlates with executive dysfunction; - to investigate if apathy is associated with a specific mechanism using an experimental task specially designed to characterise different mechanisms (i.e., "a-motivation", "cognitive inertia", and "uncoupling"); - to investigate if there is a volumetric abnormality affecting the executive system in apathetic schizophrenic patients; - to link these possible volumetric abnormalities to the prefrontal cortex-basal ganglia circuits according to a specific apathy subtype within the apathetic schizophrenic group. |
Inclusion criteria |
Healthy volunteers:
-Male or female; -Aged 20 to 55; -With health insurance. Exclusion criteria: -History of neurological disorder; -Previous head injury; -Alcohol or substance abuse; -On psychotropic medication; -Contraindication to MRI. Schizophrenia patients: -Male or female; -Aged 20 to 55; -With health insurance; -Daignosed as schizophrenic according to DSM-IV R criteria; -Illness with a duration of over 5 years; -Clinical stability during the past 2 months (defined as no treatment modification or hospitalisation 2 months prior to evaluation). Exclusion criteria: -Schizo-affective disorder; -History of neurological disorders (past or present); -Previous head injury; -Alcohol or substance abuse; -Contraindication to MRI. |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
Local |
French regions covered by the database |
Île-de-France |
Detail of the geography area | Psychiatric department in Corentin Celton Hospital |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2012 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 12 schizophrenic patients; 15 healthy volunteers. |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Paraclinical data |
Clinical data (detail) |
Medical registration |
Details of collected clinical data | Apathy (measured by Starkstein's Apathy Evaluation Scale), neuropsychological performance: global mental efficience (Mill Hill B, PM 38), frontal assessments (BREF, MCST, TMT A and B, Stroop, verbal fluences), social cognition (SEA); memory (Grober and Buschke, direct-indirect digit span), instrumental functions: Rey figure), positive and negative symptomatology: PANSS, SANS/SAPS, Calgary Scale, SDS. |
Paraclinical data (detail) | Volumetric brain abnormalities. |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity |
Procedures | |
Participant monitoring |
No |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Contact the scientist in charge. |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05